BioScrip and UnitedHealthcare to terminate specialty services contract
This contract termination will have no impact on 2008 operating results. For 2009, BioScrip expects a loss of revenue of $100 million and a loss of $2 million
SK bioscience is set to lead the Gates Foundation-fundedResearch Optimization & Trial Outcome Recommender (ROTOR) project, an AI-based platform aimed at reducing uncertainty in vaccine-development decisions.